首页 > 最新文献

Ultrasound in Obstetrics & Gynecology最新文献

英文 中文
Reply. 答复
IF 6.1 1区 医学 Q1 ACOUSTICS Pub Date : 2025-02-01 Epub Date: 2024-11-27 DOI: 10.1002/uog.29149
A Deslandes, M Leonardi
{"title":"Reply.","authors":"A Deslandes, M Leonardi","doi":"10.1002/uog.29149","DOIUrl":"10.1002/uog.29149","url":null,"abstract":"","PeriodicalId":23454,"journal":{"name":"Ultrasound in Obstetrics & Gynecology","volume":" ","pages":"245-246"},"PeriodicalIF":6.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142732939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply. 回复。
IF 6.1 1区 医学 Q1 ACOUSTICS Pub Date : 2025-02-01 Epub Date: 2024-12-17 DOI: 10.1002/uog.29161
A Deslandes, M Leonardi
{"title":"Reply.","authors":"A Deslandes, M Leonardi","doi":"10.1002/uog.29161","DOIUrl":"10.1002/uog.29161","url":null,"abstract":"","PeriodicalId":23454,"journal":{"name":"Ultrasound in Obstetrics & Gynecology","volume":" ","pages":"247-248"},"PeriodicalIF":6.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142839781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Routine 36-week scan: diagnosis and outcome of abnormal fetal presentation. 常规36周扫描:异常胎儿形态的诊断和结局。
IF 6.1 1区 医学 Q1 ACOUSTICS Pub Date : 2025-02-01 Epub Date: 2024-12-02 DOI: 10.1002/uog.29139
M Fitiri, D Papavasileiou, V Mesaric, A Syngelaki, R Akolekar, K H Nicolaides
<p><strong>Objectives: </strong>First, to report the incidence of non-cephalic presentation at a routine 36-week ultrasound scan, the uptake and success of external cephalic version (ECV) and the incidence of spontaneous rotation from non-cephalic to cephalic presentation. Second, to determine the maternal and pregnancy characteristics that provide a significant contribution to the prediction of non-cephalic presentation at the 36-week scan, successful ECV from non-cephalic to cephalic presentation and spontaneous rotation from non-cephalic to cephalic presentation.</p><p><strong>Methods: </strong>This was a retrospective analysis of prospectively collected data from 107 875 women with a singleton pregnancy who had undergone a routine ultrasound scan at 35 + 0 to 36 + 6 weeks' gestation. Patients with breech or transverse/oblique presentation were divided into two groups: those scheduled for elective Cesarean section for a fetal or maternal indication other than abnormal presentation, and those that would potentially require ECV. The latter group was reassessed after 1-2 weeks and, if the abnormal presentation persisted, the parents were offered ECV or elective Cesarean section at 38-40 weeks' gestation. Multivariable logistic regression analysis was carried out to determine which maternal and pregnancy characteristics provided a significant contribution in the prediction of non-cephalic presentation at the 36-week scan, successful ECV from non-cephalic to cephalic presentation and spontaneous rotation from non-cephalic to cephalic presentation.</p><p><strong>Results: </strong>At the 36-week scan, fetal presentation was cephalic in 101 664 (94.2%) pregnancies and either breech, transverse or oblique in 6211 (5.8%). In 0.3% of cases with cephalic presentation at the 36-week scan, there was subsequent spontaneous rotation to non-cephalic presentation, and in half of these, the diagnosis was made during labor or at birth. ECV was attempted in 1584/6211 (25.5%) pregnancies with non-cephalic presentation at the 36-week scan and was successful in only 44.1% of cases. In the remaining 74.5% of cases, ECV was not attempted because of any of the following reasons: ECV was declined; Cesarean section was planned for a reason other than abnormal presentation; ECV was planned for the subsequent 1-2 weeks but, in the meantime, there was spontaneous rotation to cephalic presentation; or there was spontaneous onset of labor or rupture of membranes before planned ECV. In 5513/6211 (88.8%) pregnancies with non-cephalic presentation at the 36-week scan, ECV was not attempted or was unsuccessful, and in 37.7% of these, there was subsequent spontaneous rotation to cephalic presentation. Among the 6211 pregnancies with non-cephalic presentation at the 36-week scan, the presentation at birth was cephalic in 43.8%; in 74.8%, this was due to spontaneous rotation, and in 25.2%, it was due to successful ECV. Multivariable analysis demonstrated that the likelihood of non-ce
目的:首先,报告在常规36周超声扫描中出现非头位表现的发生率,头外显像(ECV)的接受和成功,以及从非头位到头位的自发旋转的发生率。其次,确定在36周扫描时对预测非头位表现有重要贡献的产妇和妊娠特征,从非头位到头位的成功ECV以及从非头位到头位的自发旋转。方法:回顾性分析前瞻性收集的107875例单胎妊娠妇女的资料,这些妇女在妊娠35 + 0至36 + 6周期间接受了常规超声扫描。臀位或横位/斜位剖宫产的患者被分为两组:因胎儿或母体指征而非异常剖宫产的患者和可能需要ECV的患者。后一组在1-2周后重新评估,如果异常表现持续存在,父母在妊娠38-40周进行ECV或择期剖宫产。进行多变量logistic回归分析,以确定哪些母体和妊娠特征在预测36周扫描时的非头位表现、成功的ECV从非头位表现到头位表现以及从非头位到头位表现的自发旋转方面提供了重要贡献。结果:在36周的扫描中,101,664例(94.2%)孕妇胎儿为头位,6211例(5.8%)胎儿为臀位、横位或斜位。在36周扫描时出现头位的病例中,有0.3%的病例随后自发转到非头位,其中一半的病例是在分娩或出生时诊断的。在1584/6211例(25.5%)孕妇中,在36周扫描时出现非头侧表现,尝试ECV,成功率仅为44.1%。在其余74.5%的病例中,由于以下任何原因,没有尝试ECV: ECV被拒绝;剖宫产并非因胎位异常所致;ECV计划在随后的1-2周内进行,但在此期间,出现了自发的向头位旋转;或在计划ECV前出现自发性分娩或胎膜破裂。在5513/6211例(88.8%)在36周扫描时出现非头位的妊娠中,没有尝试ECV或未成功,其中37.7%的妊娠随后自发旋转至头位。在6211例在36周扫描时出现非头位表现的孕妇中,出生时出现头位表现的占43.8%;74.8%是由于自发旋转,25.2%是由于成功的ECV。多变量分析表明,36周扫描时出现非头位的可能性、ECV成功出现的可能性以及从非头位到头位的自发旋转的可能性受到一些母体和妊娠特征的影响,但这些事件的预测性能较差,受体-操作-特征曲线下面积范围为0.608 ~ 0.717,10%的假阳性率检出率范围为19.0% ~ 33.7%。结论:妊娠35 + 0 ~ 36 + 6周常规超声检查可显著降低产程出现意外异常的风险,改善妊娠结局。然而,当所有妇女在分娩时,应考虑对胎儿进行额外的超声扫描。©2024作者。妇产科学超声由John Wiley & Sons Ltd代表国际妇产科学超声学会出版。
{"title":"Routine 36-week scan: diagnosis and outcome of abnormal fetal presentation.","authors":"M Fitiri, D Papavasileiou, V Mesaric, A Syngelaki, R Akolekar, K H Nicolaides","doi":"10.1002/uog.29139","DOIUrl":"10.1002/uog.29139","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;First, to report the incidence of non-cephalic presentation at a routine 36-week ultrasound scan, the uptake and success of external cephalic version (ECV) and the incidence of spontaneous rotation from non-cephalic to cephalic presentation. Second, to determine the maternal and pregnancy characteristics that provide a significant contribution to the prediction of non-cephalic presentation at the 36-week scan, successful ECV from non-cephalic to cephalic presentation and spontaneous rotation from non-cephalic to cephalic presentation.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;This was a retrospective analysis of prospectively collected data from 107 875 women with a singleton pregnancy who had undergone a routine ultrasound scan at 35 + 0 to 36 + 6 weeks' gestation. Patients with breech or transverse/oblique presentation were divided into two groups: those scheduled for elective Cesarean section for a fetal or maternal indication other than abnormal presentation, and those that would potentially require ECV. The latter group was reassessed after 1-2 weeks and, if the abnormal presentation persisted, the parents were offered ECV or elective Cesarean section at 38-40 weeks' gestation. Multivariable logistic regression analysis was carried out to determine which maternal and pregnancy characteristics provided a significant contribution in the prediction of non-cephalic presentation at the 36-week scan, successful ECV from non-cephalic to cephalic presentation and spontaneous rotation from non-cephalic to cephalic presentation.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;At the 36-week scan, fetal presentation was cephalic in 101 664 (94.2%) pregnancies and either breech, transverse or oblique in 6211 (5.8%). In 0.3% of cases with cephalic presentation at the 36-week scan, there was subsequent spontaneous rotation to non-cephalic presentation, and in half of these, the diagnosis was made during labor or at birth. ECV was attempted in 1584/6211 (25.5%) pregnancies with non-cephalic presentation at the 36-week scan and was successful in only 44.1% of cases. In the remaining 74.5% of cases, ECV was not attempted because of any of the following reasons: ECV was declined; Cesarean section was planned for a reason other than abnormal presentation; ECV was planned for the subsequent 1-2 weeks but, in the meantime, there was spontaneous rotation to cephalic presentation; or there was spontaneous onset of labor or rupture of membranes before planned ECV. In 5513/6211 (88.8%) pregnancies with non-cephalic presentation at the 36-week scan, ECV was not attempted or was unsuccessful, and in 37.7% of these, there was subsequent spontaneous rotation to cephalic presentation. Among the 6211 pregnancies with non-cephalic presentation at the 36-week scan, the presentation at birth was cephalic in 43.8%; in 74.8%, this was due to spontaneous rotation, and in 25.2%, it was due to successful ECV. Multivariable analysis demonstrated that the likelihood of non-ce","PeriodicalId":23454,"journal":{"name":"Ultrasound in Obstetrics & Gynecology","volume":" ","pages":"154-162"},"PeriodicalIF":6.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11788461/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142772746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combined first-trimester screening for preterm small-for-gestational-age infants: Australian multicenter clinical feasibility study. 联合早期筛查早产小于胎龄儿:澳大利亚多中心临床可行性研究。
IF 6.1 1区 医学 Q1 ACOUSTICS Pub Date : 2025-02-01 Epub Date: 2025-01-18 DOI: 10.1002/uog.29174
R J Selvaratnam, D L Rolnik, M Setterfield, E M Wallace, J A Hyett, F Da Silva Costa, A C McLennan

Objective: To assess the performance of the Fetal Medicine Foundation (FMF) first-trimester competing-risks screening model for small-for-gestational-age (SGA) fetuses requiring delivery at < 37 weeks' gestation, in a large cohort of women receiving maternity care in Australia.

Methods: This was a retrospective analysis of prospectively collected data from a cohort of women attending one of two private multicenter fetal medicine practices for first-trimester screening for preterm pre-eclampsia (PE), defined as PE requiring delivery before 37 weeks' gestation. Risk for preterm SGA, defined as SGA requiring delivery before 37 weeks, was calculated but was not disclosed to the patient or referring physician. Screening data were matched to obstetric outcomes. The primary outcome was the efficacy of the FMF screening model in assessing the risk of preterm SGA. The potential effect on identifying other adverse pregnancy outcomes was also assessed.

Results: During the study period, 22 841 women with a singleton pregnancy underwent combined first-trimester screening for preterm PE. These data were compared with those of 301 721 women in the state of Victoria with a singleton pregnancy who did not undergo screening during the study period. Calculation of the risk for preterm SGA identified 3030 (13.3%) pregnancies as high risk. The sensitivity of the model was 48.6% (95% CI, 41.0-56.2%), specificity was 87.0% (95% CI, 86.6-87.5%) and positive and negative predictive values were 2.9% (95% CI, 2.7-3.1%) and 99.5% (95% CI, 99.4-99.6%), respectively. Pregnancies at high risk for preterm SGA were also more likely to have preterm PE (risk ratio (RR), 2.28 (95% CI, 1.72-3.03)) and preterm birth (RR, 1.46 (95% CI, 1.32-1.63)), compared with unscreened pregnancies. Pregnancies at low risk for preterm SGA were less likely to result in a stillbirth (RR, 0.64 (95% CI, 0.47-0.86)) compared with unscreened pregnancies.

Conclusion: Combined first-trimester screening for preterm SGA shows moderate screening efficacy and therefore could help to inform pregnancy management and improve antenatal resource allocation. © 2025 International Society of Ultrasound in Obstetrics and Gynecology.

目的:评估胎儿医学基金会(FMF)早期妊娠竞争风险筛查模型在需要分娩的小胎龄(SGA)胎儿中的表现:这是一项回顾性分析,前瞻性收集了一组妇女的数据,这些妇女参加了两个私人多中心胎儿医学实践之一,用于早期筛查早产先兆子痫(PE),定义为需要在妊娠37周前分娩的PE。早产SGA的风险(定义为需要在37周前分娩的SGA)被计算,但未向患者或转诊医生披露。筛查数据与产科结果相匹配。主要结果是FMF筛选模型在评估早产SGA风险方面的有效性。对其他不良妊娠结局的潜在影响也进行了评估。结果:在研究期间,22 841名单胎妊娠妇女接受了联合妊娠早期PE筛查。这些数据与维多利亚州301 721名在研究期间没有接受筛查的单胎妊娠妇女的数据进行了比较。通过计算SGA早产风险,3030例(13.3%)妊娠属于高危妊娠。该模型的敏感性为48.6% (95% CI, 41.0 ~ 56.2%),特异性为87.0% (95% CI, 86.6 ~ 87.5%),阳性预测值和阴性预测值分别为2.9% (95% CI, 2.7 ~ 3.1%)和99.5% (95% CI, 99.4 ~ 99.6%)。与未筛查的妊娠相比,早产SGA高风险妊娠也更容易发生早产PE(风险比(RR), 2.28 (95% CI, 1.72-3.03))和早产(RR, 1.46 (95% CI, 1.32-1.63))。与未筛查的妊娠相比,早产SGA风险低的妊娠不太可能导致死产(RR, 0.64 (95% CI, 0.47-0.86))。结论:早期联合筛查对早产儿SGA的筛查效果中等,有助于妊娠管理和改善产前资源配置。©2025国际妇产科超声学会。
{"title":"Combined first-trimester screening for preterm small-for-gestational-age infants: Australian multicenter clinical feasibility study.","authors":"R J Selvaratnam, D L Rolnik, M Setterfield, E M Wallace, J A Hyett, F Da Silva Costa, A C McLennan","doi":"10.1002/uog.29174","DOIUrl":"10.1002/uog.29174","url":null,"abstract":"<p><strong>Objective: </strong>To assess the performance of the Fetal Medicine Foundation (FMF) first-trimester competing-risks screening model for small-for-gestational-age (SGA) fetuses requiring delivery at < 37 weeks' gestation, in a large cohort of women receiving maternity care in Australia.</p><p><strong>Methods: </strong>This was a retrospective analysis of prospectively collected data from a cohort of women attending one of two private multicenter fetal medicine practices for first-trimester screening for preterm pre-eclampsia (PE), defined as PE requiring delivery before 37 weeks' gestation. Risk for preterm SGA, defined as SGA requiring delivery before 37 weeks, was calculated but was not disclosed to the patient or referring physician. Screening data were matched to obstetric outcomes. The primary outcome was the efficacy of the FMF screening model in assessing the risk of preterm SGA. The potential effect on identifying other adverse pregnancy outcomes was also assessed.</p><p><strong>Results: </strong>During the study period, 22 841 women with a singleton pregnancy underwent combined first-trimester screening for preterm PE. These data were compared with those of 301 721 women in the state of Victoria with a singleton pregnancy who did not undergo screening during the study period. Calculation of the risk for preterm SGA identified 3030 (13.3%) pregnancies as high risk. The sensitivity of the model was 48.6% (95% CI, 41.0-56.2%), specificity was 87.0% (95% CI, 86.6-87.5%) and positive and negative predictive values were 2.9% (95% CI, 2.7-3.1%) and 99.5% (95% CI, 99.4-99.6%), respectively. Pregnancies at high risk for preterm SGA were also more likely to have preterm PE (risk ratio (RR), 2.28 (95% CI, 1.72-3.03)) and preterm birth (RR, 1.46 (95% CI, 1.32-1.63)), compared with unscreened pregnancies. Pregnancies at low risk for preterm SGA were less likely to result in a stillbirth (RR, 0.64 (95% CI, 0.47-0.86)) compared with unscreened pregnancies.</p><p><strong>Conclusion: </strong>Combined first-trimester screening for preterm SGA shows moderate screening efficacy and therefore could help to inform pregnancy management and improve antenatal resource allocation. © 2025 International Society of Ultrasound in Obstetrics and Gynecology.</p>","PeriodicalId":23454,"journal":{"name":"Ultrasound in Obstetrics & Gynecology","volume":" ","pages":"183-190"},"PeriodicalIF":6.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143012418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of uterine fibroids with late miscarriage: multicenter cohort study.
IF 6.1 1区 医学 Q1 ACOUSTICS Pub Date : 2025-02-01 DOI: 10.1002/uog.29169
A Siargkas, M Del Mar Gil Mira, P Chaveeva, C de Paco Matallana, M Impis Oglou, M Muñoz-Contreras, V Kalev, L Gonzalez-Gea, I Fernandez-Buhigas, J Sanchez-Romero, I Tsakiridis, T Dagklis
<p><strong>Objective: </strong>To investigate the correlation between the number, location and size of uterine fibroids and the incidence of late miscarriage during pregnancy.</p><p><strong>Methods: </strong>This was a retrospective, multicenter cohort study of singleton pregnancies, with a live fetus at the first-trimester ultrasound examination, without known genetic anomalies or major fetal defects, from January 2012 to December 2022. We assessed the impact of fibroids and their characteristics, identified on ultrasound imaging at 11 + 0 to 13 + 6 weeks, on the risk of late miscarriage occurring at 11 + 0 to 21 + 6 weeks. Fibroid number, location and size were investigated, and adjusted odds ratios (aORs) with 95% CIs were calculated using multiple logistic regression and propensity score analysis via inverse probability of treatment weighting (IPTW) to minimize confounding. Singleton pregnancies without uterine fibroids comprised the control group. We further calculated the adjusted absolute risk (aAR) for the control group and the adjusted risk differences (aRD) for the study groups.</p><p><strong>Results: </strong>In total, 31 355 singleton pregnancies were analyzed, of which 942 (3.0%) had uterine fibroids. Multiple logistic regression analysis showed that pregnancies with a single fibroid did not have higher odds for late miscarriage compared to those without fibroids (aOR, 1.2 (95% CI, 0.6-2.4)), but women with multiple fibroids did have higher odds of late miscarriage (aOR, 2.5 (95% CI, 1.0-6.2)). Similarly, multiple logistic regression analysis after IPTW did not find higher odds of late miscarriage in pregnancies with a single fibroid (aOR, 1.7 (95% CI, 0.9-3.0) and aRD, 0.7% (95% CI, -0.2 to 2.1%)) but revealed increased odds of late miscarriage in women with multiple fibroids (aOR, 2.9 (95% CI, 1.1-7.3) and aRD, 2.0% (95% CI, -0.6 to 9.7%)). Analysis of the location of single fibroids revealed that submucosal fibroids significantly increased the odds of late miscarriage by 4.7 times, while the presence of fibroids in other locations did not have a statistically significant association with late miscarriage. When we limited our study population to cases with submucosal and intramural fibroids, logistic regression showed no significant increase in the odds of miscarriage for a single fibroid (aOR, 1.8 (95% CI, 0.9-3.5) and aRD, 1.2% (95% CI, -0.1 to 3.1%)), but revealed significantly higher odds for multiple fibroids (aOR, 3.8 (95% CI, 1.4-10.6) and aRD, 5.1% (95% CI, 0.6-22.0%)) compared with controls. IPTW analysis found a 2.3-fold increase in the odds of late miscarriage for a single fibroid (aOR, 2.3 (95% CI, 1.2-4.2)) and an even larger increase in the odds of late miscarriage for multiple fibroids (aOR, 5.7 (95% CI, 2.2-15.1)).</p><p><strong>Conclusion: </strong>Uterine fibroids are associated with increased odds of late miscarriage, particularly when they are multiple and submucosal. © 2025 International Society of Ultrasound i
{"title":"Association of uterine fibroids with late miscarriage: multicenter cohort study.","authors":"A Siargkas, M Del Mar Gil Mira, P Chaveeva, C de Paco Matallana, M Impis Oglou, M Muñoz-Contreras, V Kalev, L Gonzalez-Gea, I Fernandez-Buhigas, J Sanchez-Romero, I Tsakiridis, T Dagklis","doi":"10.1002/uog.29169","DOIUrl":"https://doi.org/10.1002/uog.29169","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To investigate the correlation between the number, location and size of uterine fibroids and the incidence of late miscarriage during pregnancy.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;This was a retrospective, multicenter cohort study of singleton pregnancies, with a live fetus at the first-trimester ultrasound examination, without known genetic anomalies or major fetal defects, from January 2012 to December 2022. We assessed the impact of fibroids and their characteristics, identified on ultrasound imaging at 11 + 0 to 13 + 6 weeks, on the risk of late miscarriage occurring at 11 + 0 to 21 + 6 weeks. Fibroid number, location and size were investigated, and adjusted odds ratios (aORs) with 95% CIs were calculated using multiple logistic regression and propensity score analysis via inverse probability of treatment weighting (IPTW) to minimize confounding. Singleton pregnancies without uterine fibroids comprised the control group. We further calculated the adjusted absolute risk (aAR) for the control group and the adjusted risk differences (aRD) for the study groups.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;In total, 31 355 singleton pregnancies were analyzed, of which 942 (3.0%) had uterine fibroids. Multiple logistic regression analysis showed that pregnancies with a single fibroid did not have higher odds for late miscarriage compared to those without fibroids (aOR, 1.2 (95% CI, 0.6-2.4)), but women with multiple fibroids did have higher odds of late miscarriage (aOR, 2.5 (95% CI, 1.0-6.2)). Similarly, multiple logistic regression analysis after IPTW did not find higher odds of late miscarriage in pregnancies with a single fibroid (aOR, 1.7 (95% CI, 0.9-3.0) and aRD, 0.7% (95% CI, -0.2 to 2.1%)) but revealed increased odds of late miscarriage in women with multiple fibroids (aOR, 2.9 (95% CI, 1.1-7.3) and aRD, 2.0% (95% CI, -0.6 to 9.7%)). Analysis of the location of single fibroids revealed that submucosal fibroids significantly increased the odds of late miscarriage by 4.7 times, while the presence of fibroids in other locations did not have a statistically significant association with late miscarriage. When we limited our study population to cases with submucosal and intramural fibroids, logistic regression showed no significant increase in the odds of miscarriage for a single fibroid (aOR, 1.8 (95% CI, 0.9-3.5) and aRD, 1.2% (95% CI, -0.1 to 3.1%)), but revealed significantly higher odds for multiple fibroids (aOR, 3.8 (95% CI, 1.4-10.6) and aRD, 5.1% (95% CI, 0.6-22.0%)) compared with controls. IPTW analysis found a 2.3-fold increase in the odds of late miscarriage for a single fibroid (aOR, 2.3 (95% CI, 1.2-4.2)) and an even larger increase in the odds of late miscarriage for multiple fibroids (aOR, 5.7 (95% CI, 2.2-15.1)).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Uterine fibroids are associated with increased odds of late miscarriage, particularly when they are multiple and submucosal. © 2025 International Society of Ultrasound i","PeriodicalId":23454,"journal":{"name":"Ultrasound in Obstetrics & Gynecology","volume":"65 2","pages":"198-205"},"PeriodicalIF":6.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143081176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prediction of pre-eclampsia using maternal hemodynamic parameters at 12 + 0 to 15 + 6 weeks. 利用母体血流动力学参数预测子痫前期12 + 0 ~ 15 + 6周。
IF 6.1 1区 医学 Q1 ACOUSTICS Pub Date : 2025-02-01 Epub Date: 2025-01-18 DOI: 10.1002/uog.29177
X Wang, D S Sahota, L Wong, L Nguyen-Hoang, Y Chen, A S T Tai, F Liu, S Ling Lau, A P W Lee, L C Poon
<p><strong>Objectives: </strong>To compare the maternal hemodynamic profile at 12 + 0 to 15 + 6 weeks' gestation in women who subsequently developed pre-eclampsia (PE) and those who did not, and to assess the screening performance of maternal hemodynamic parameters for PE in combination with the Fetal Medicine Foundation (FMF) triple test, including maternal factors (MF), mean arterial pressure (MAP), uterine artery pulsatility index and placental growth factor.</p><p><strong>Methods: </strong>This was a prospective case-control study involving Chinese women with a singleton pregnancy who underwent preterm PE screening at 11 + 0 to 13 + 6 weeks' gestation using the FMF triple test, between February 2020 and February 2023. Women identified as being at high risk (≥ 1:100) for preterm PE by the FMF triple test were matched 1:1 with women identified as low risk (< 1:100) for maternal age ± 3 years, maternal weight ± 5 kg and date of screening ± 14 days. Two-dimensional transthoracic echocardiography was performed at 12 + 0 to 15 + 6 weeks to evaluate maternal hemodynamic parameters (heart rate (HR), stroke volume (SV), cardiac output (CO) and systemic vascular resistance (SVR)). Maternal hemodynamic parameters were expressed as multiples of the median (MoM) values, determined by linear regression models to adjust for gestational age (GA) and MF. The distribution of log<sub>10</sub> MoM values of maternal hemodynamic parameters in cases of PE and unaffected pregnancies, and the association between these hemodynamic parameters and GA at delivery, were assessed. The risks of preterm PE (delivery before 37 weeks) and any-onset PE (delivery at any time) were reassessed using Bayes' theorem after maternal hemodynamic parameters were added to the FMF triple test. The screening performance for preterm PE and any-onset PE was determined by the area under the receiver-operating-characteristics curve (AUC) and detection rate at a 10% fixed false-positive rate (FPR). Differences in AUC (ΔAUC) were assessed using DeLong's test.</p><p><strong>Results: </strong>A total of 743 cases were analyzed, of whom 39 (5.2%) subsequently developed PE, including 29 (3.9%) cases of preterm PE and 10 (1.3%) cases of term PE. Mean log<sub>10</sub> SVR MoM was significantly higher in cases of preterm PE and any-onset PE compared with unaffected pregnancies. Mean log<sub>10</sub> SV MoM and log<sub>10</sub> CO MoM were significantly lower in cases of preterm PE and any-onset PE compared with unaffected pregnancies. Mean log<sub>10</sub> HR MoM was not significantly different between the study groups. Mean log<sub>10</sub> CO MoM and log<sub>10</sub> SVR MoM were not significantly correlated with GA at delivery in preterm PE and any-onset PE. For the prediction of preterm PE and any-onset PE, adding CO or SVR or replacing MAP with CO and SVR in the FMF triple test achieved an identical or greater AUC compared with the FMF triple test, but ΔAUC was not significantly different. In add
目的:比较妊娠12 + 0 ~ 15 + 6周发生子痫前期(PE)与未发生子痫前期(PE)的产妇血流动力学特征,并结合胎儿医学基金会(FMF)三联试验,包括母体因子(MF)、平均动脉压(MAP)、子宫动脉搏动指数和胎盘生长因子,评价母体血流动力学参数对PE的筛查效果。方法:这是一项前瞻性病例对照研究,在2020年2月至2023年2月期间,中国单胎妊娠妇女在妊娠11 + 0至13 + 6周期间使用FMF三重试验进行了早产PE筛查。通过FMF三联试验确定为早产PE高风险(≥1:100)的妇女与确定为低风险的妇女(在PE和未受影响的妊娠中母体血液动力学参数的10个MoM值,以及这些血液动力学参数与分娩时GA之间的关系)进行1:1匹配。在FMF三联试验中加入母体血流动力学参数后,使用贝叶斯定理重新评估早产PE(37周前分娩)和任何起病PE(任何时间分娩)的风险。在10%的固定假阳性率(FPR)下,通过受体工作特征曲线下面积(AUC)和检出率来确定早产儿PE和任何发病PE的筛查效果。采用DeLong’s test评估AUC差异(ΔAUC)。结果:共分析743例,其中39例(5.2%)发展为PE,其中早产PE 29例(3.9%),足月PE 10例(1.3%)。与未受影响的妊娠相比,早产PE和任何发病PE的平均log10 SVR MoM显著更高。与未受影响的妊娠相比,早产PE和任何发病PE的平均log10 SV MoM和log10 CO MoM显著降低。平均log10 HR MoM在研究组之间没有显著差异。在早产PE和任何发病PE中,平均log10 CO MoM和log10 SVR MoM与分娩GA无显著相关。对于早产PE和任何发病PE的预测,FMF三联试验中添加CO或SVR或用CO和SVR代替MAP获得的AUC与FMF三联试验相同或更高,但ΔAUC无显著差异。此外,在FMF三联检验中添加CO或SVR或以CO和SVR代替MAP,在固定FPR为10%时,并没有提高早产儿PE和任何发病PE的检出率。结论:在PE临床表现明显之前,早产PE或任何起病PE的女性SVR升高,CO降低。这些变化可以作为心血管不适应的早期指标。然而,在12 + 0至15 + 6周评估母体血液动力学并不能提高这些参数的早产儿PE和任何起病PE的筛查效果。FMF三联试验在预测PE方面仍优于其他生物标志物组合。©2025作者。妇产科学超声由John Wiley & Sons Ltd代表国际妇产科学超声学会出版。
{"title":"Prediction of pre-eclampsia using maternal hemodynamic parameters at 12 + 0 to 15 + 6 weeks.","authors":"X Wang, D S Sahota, L Wong, L Nguyen-Hoang, Y Chen, A S T Tai, F Liu, S Ling Lau, A P W Lee, L C Poon","doi":"10.1002/uog.29177","DOIUrl":"10.1002/uog.29177","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;To compare the maternal hemodynamic profile at 12 + 0 to 15 + 6 weeks' gestation in women who subsequently developed pre-eclampsia (PE) and those who did not, and to assess the screening performance of maternal hemodynamic parameters for PE in combination with the Fetal Medicine Foundation (FMF) triple test, including maternal factors (MF), mean arterial pressure (MAP), uterine artery pulsatility index and placental growth factor.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;This was a prospective case-control study involving Chinese women with a singleton pregnancy who underwent preterm PE screening at 11 + 0 to 13 + 6 weeks' gestation using the FMF triple test, between February 2020 and February 2023. Women identified as being at high risk (≥ 1:100) for preterm PE by the FMF triple test were matched 1:1 with women identified as low risk (&lt; 1:100) for maternal age ± 3 years, maternal weight ± 5 kg and date of screening ± 14 days. Two-dimensional transthoracic echocardiography was performed at 12 + 0 to 15 + 6 weeks to evaluate maternal hemodynamic parameters (heart rate (HR), stroke volume (SV), cardiac output (CO) and systemic vascular resistance (SVR)). Maternal hemodynamic parameters were expressed as multiples of the median (MoM) values, determined by linear regression models to adjust for gestational age (GA) and MF. The distribution of log&lt;sub&gt;10&lt;/sub&gt; MoM values of maternal hemodynamic parameters in cases of PE and unaffected pregnancies, and the association between these hemodynamic parameters and GA at delivery, were assessed. The risks of preterm PE (delivery before 37 weeks) and any-onset PE (delivery at any time) were reassessed using Bayes' theorem after maternal hemodynamic parameters were added to the FMF triple test. The screening performance for preterm PE and any-onset PE was determined by the area under the receiver-operating-characteristics curve (AUC) and detection rate at a 10% fixed false-positive rate (FPR). Differences in AUC (ΔAUC) were assessed using DeLong's test.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 743 cases were analyzed, of whom 39 (5.2%) subsequently developed PE, including 29 (3.9%) cases of preterm PE and 10 (1.3%) cases of term PE. Mean log&lt;sub&gt;10&lt;/sub&gt; SVR MoM was significantly higher in cases of preterm PE and any-onset PE compared with unaffected pregnancies. Mean log&lt;sub&gt;10&lt;/sub&gt; SV MoM and log&lt;sub&gt;10&lt;/sub&gt; CO MoM were significantly lower in cases of preterm PE and any-onset PE compared with unaffected pregnancies. Mean log&lt;sub&gt;10&lt;/sub&gt; HR MoM was not significantly different between the study groups. Mean log&lt;sub&gt;10&lt;/sub&gt; CO MoM and log&lt;sub&gt;10&lt;/sub&gt; SVR MoM were not significantly correlated with GA at delivery in preterm PE and any-onset PE. For the prediction of preterm PE and any-onset PE, adding CO or SVR or replacing MAP with CO and SVR in the FMF triple test achieved an identical or greater AUC compared with the FMF triple test, but ΔAUC was not significantly different. In add","PeriodicalId":23454,"journal":{"name":"Ultrasound in Obstetrics & Gynecology","volume":" ","pages":"173-182"},"PeriodicalIF":6.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11788463/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143012367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound assessment of lymph nodes for staging of gynecological cancer: consensus opinion on terminology and examination technique. 妇科癌症分期中的淋巴结超声评估:术语和检查技术的共识意见。
IF 6.1 1区 医学 Q1 ACOUSTICS Pub Date : 2025-02-01 Epub Date: 2024-11-08 DOI: 10.1002/uog.29127
D Fischerova, E Gatti, C Culcasi, Z Ng, G Szabó, L Zanchi, A Burgetova, O Nanka, G Gambino, M R Kadajari, G Garganese

The lymphatic pathway is an important route of metastasis in gynecological malignancy. Therefore, the examination of lymph nodes is an essential part of the ultrasound evaluation in patients with known or suspected gynecological malignancy. The lymph nodes most frequently involved in gynecological malignancy (apart from vulvar cancer) are parietal (retroperitoneal) and visceral abdominopelvic lymph nodes. In advanced disease, more distant lymph-node regions, such as the inguinal, axillary and supraclavicular lymph nodes, can also be involved. The standardized description of lymph nodes has been published previously by the Vulvar International Tumor Analysis (VITA) collaborative group. Herein, a collaborative group of gynecologists and gynecological oncologists with extensive ultrasound experience presents a systematic methodology for ultrasonographic lymph-node assessment performed as part of the locoregional and distant work-up to assess the extent of gynecological malignancy. The aim of this consensus opinion is also to describe the anatomical classification and drainage pathways of the lymphatic system as relevant to the gynecological organs. © 2024 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

淋巴途径是妇科恶性肿瘤转移的重要途径。因此,对已知或疑似妇科恶性肿瘤患者进行超声评估时,淋巴结检查是必不可少的一部分。妇科恶性肿瘤(除外阴癌外)最常累及的淋巴结是腹膜旁(腹膜后)和内脏腹盆腔淋巴结。在晚期疾病中,腹股沟淋巴结、腋窝淋巴结和锁骨上淋巴结等更远处的淋巴结区域也可能受累。外阴国际肿瘤分析(VITA)协作组曾发表过淋巴结的标准化描述。在此,由具有丰富超声经验的妇科专家和妇科肿瘤专家组成的协作组提出了一套系统的淋巴结超声评估方法,作为局部和远处检查的一部分,用于评估妇科恶性肿瘤的范围。本共识意见还旨在描述与妇科器官相关的淋巴系统解剖学分类和引流途径。作者:© 2024。妇产科超声》由 John Wiley & Sons Ltd 代表国际妇产科超声学会出版。
{"title":"Ultrasound assessment of lymph nodes for staging of gynecological cancer: consensus opinion on terminology and examination technique.","authors":"D Fischerova, E Gatti, C Culcasi, Z Ng, G Szabó, L Zanchi, A Burgetova, O Nanka, G Gambino, M R Kadajari, G Garganese","doi":"10.1002/uog.29127","DOIUrl":"10.1002/uog.29127","url":null,"abstract":"<p><p>The lymphatic pathway is an important route of metastasis in gynecological malignancy. Therefore, the examination of lymph nodes is an essential part of the ultrasound evaluation in patients with known or suspected gynecological malignancy. The lymph nodes most frequently involved in gynecological malignancy (apart from vulvar cancer) are parietal (retroperitoneal) and visceral abdominopelvic lymph nodes. In advanced disease, more distant lymph-node regions, such as the inguinal, axillary and supraclavicular lymph nodes, can also be involved. The standardized description of lymph nodes has been published previously by the Vulvar International Tumor Analysis (VITA) collaborative group. Herein, a collaborative group of gynecologists and gynecological oncologists with extensive ultrasound experience presents a systematic methodology for ultrasonographic lymph-node assessment performed as part of the locoregional and distant work-up to assess the extent of gynecological malignancy. The aim of this consensus opinion is also to describe the anatomical classification and drainage pathways of the lymphatic system as relevant to the gynecological organs. © 2024 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.</p>","PeriodicalId":23454,"journal":{"name":"Ultrasound in Obstetrics & Gynecology","volume":" ","pages":"206-225"},"PeriodicalIF":6.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Three-dimensional ultrasound demonstration of boomerang vessel of Type-III vasa previa at 21 weeks' gestation.
IF 6.1 1区 医学 Q1 ACOUSTICS Pub Date : 2025-01-31 DOI: 10.1002/uog.29176
K Senthilvel, V Ravindran, K C Arivarasan, N Karthikeyan
{"title":"Three-dimensional ultrasound demonstration of boomerang vessel of Type-III vasa previa at 21 weeks' gestation.","authors":"K Senthilvel, V Ravindran, K C Arivarasan, N Karthikeyan","doi":"10.1002/uog.29176","DOIUrl":"https://doi.org/10.1002/uog.29176","url":null,"abstract":"","PeriodicalId":23454,"journal":{"name":"Ultrasound in Obstetrics & Gynecology","volume":" ","pages":""},"PeriodicalIF":6.1,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143068290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mixed germ cell tumor presenting with mixed sonographic appearance and unique clinical presentation.
IF 6.1 1区 医学 Q1 ACOUSTICS Pub Date : 2025-01-24 DOI: 10.1002/uog.29179
S Dumont, F Amant, W Froyman, D Timmerman, A-S Van Rompuy, T Van den Bosch
{"title":"Mixed germ cell tumor presenting with mixed sonographic appearance and unique clinical presentation.","authors":"S Dumont, F Amant, W Froyman, D Timmerman, A-S Van Rompuy, T Van den Bosch","doi":"10.1002/uog.29179","DOIUrl":"https://doi.org/10.1002/uog.29179","url":null,"abstract":"","PeriodicalId":23454,"journal":{"name":"Ultrasound in Obstetrics & Gynecology","volume":" ","pages":""},"PeriodicalIF":6.1,"publicationDate":"2025-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143041677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility and acceptability of randomized controlled trial of intervention vs expectant management for early-onset selective fetal growth restriction in monochorionic twin pregnancy.
IF 6.1 1区 医学 Q1 ACOUSTICS Pub Date : 2025-01-24 DOI: 10.1002/uog.29175
A Khalil, S Prasad, J J Kirkham, R Jackson, K Woolfall
{"title":"Feasibility and acceptability of randomized controlled trial of intervention vs expectant management for early-onset selective fetal growth restriction in monochorionic twin pregnancy.","authors":"A Khalil, S Prasad, J J Kirkham, R Jackson, K Woolfall","doi":"10.1002/uog.29175","DOIUrl":"https://doi.org/10.1002/uog.29175","url":null,"abstract":"","PeriodicalId":23454,"journal":{"name":"Ultrasound in Obstetrics & Gynecology","volume":" ","pages":""},"PeriodicalIF":6.1,"publicationDate":"2025-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143041632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Ultrasound in Obstetrics & Gynecology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1